Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells.
about
Research progress on Livin protein: an inhibitor of apoptosisThe USP19 deubiquitinase regulates the stability of c-IAP1 and c-IAP2Livin promotes Smac/DIABLO degradation by ubiquitin-proteasome pathwaySmall-molecule SMAC mimetics as new cancer therapeuticsInteraction of heat-shock protein 90 beta isoform (HSP90 beta) with cellular inhibitor of apoptosis 1 (c-IAP1) is required for cell differentiationEctopic expression of new alternative splice variant of Smac/DIABLO increases mammospheres formationRegulation of tumour necrosis factor signalling: live or let dieSmall molecules destabilize cIAP1 by activating auto-ubiquitylationSmac modulates chemosensitivity in head and neck cancer cells through the mitochondrial apoptotic pathwayHigh Smac/DIABLO expression is associated with early local recurrence of cervical cancerAn unconventional IAP-binding motif revealed by target-assisted iterative screening (TAIS) of the BIR3-cIAP1 domain.Auto-ubiquitination-induced degradation of MALT1-API2 prevents BCL10 destabilization in t(11;18)(q21;q21)-positive MALT lymphoma.Conjugation to a SMAC mimetic potentiates sigma-2 ligand induced tumor cell death in ovarian cancerPoly(I:C) induces intense expression of c-IAP2 and cooperates with an IAP inhibitor in induction of apoptosis in cancer cells.Monomerization of cytosolic mature smac attenuates interaction with IAPs and potentiation of caspase activationTumor necrosis factor (TNF) signaling, but not TWEAK (TNF-like weak inducer of apoptosis)-triggered cIAP1 (cellular inhibitor of apoptosis protein 1) degradation, requires cIAP1 RING dimerization and E2 binding.Killer proteases and little strokes--how the things that do not kill you make you stronger.Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundancecIAP1 cooperatively inhibits procaspase-3 activation by the caspase-9 apoptosomeThe HIV-1 Vpu protein induces apoptosis in Drosophila via activation of JNK signalingCellular inhibitor of apoptosis protein-1 (cIAP1) plays a critical role in β-cell survival under endoplasmic reticulum stress: promoting ubiquitination and degradation of C/EBP homologous protein (CHOP)Cyclopeptide Smac mimetics as antagonists of IAP proteins.Novel link between E2F1 and Smac/DIABLO: proapoptotic Smac/DIABLO is transcriptionally upregulated by E2F1.Cadmium down-regulates expression of XIAP at the post-transcriptional level in prostate cancer cells through an NF-kappaB-independent, proteasome-mediated mechanism.HAX1 regulates E3 ubiquitin ligase activity of cIAPs by promoting their dimerizationSmac mimetics increase cancer cell response to chemotherapeutics in a TNF-α-dependent mannerSplice variants of mIAP1 have an enhanced ability to inhibit apoptosisTRIM32 protein sensitizes cells to tumor necrosis factor (TNFα)-induced apoptosis via its RING domain-dependent E3 ligase activity against X-linked inhibitor of apoptosis (XIAP).Immune unresponsiveness to secondary heterologous bacterial infection after sepsis induction is TRAIL dependentThe IAP-antagonist ARTS initiates caspase activation upstream of cytochrome C and SMAC/Diablo.Inhibitor of apoptosis proteins as intracellular signaling intermediates.Molecular characterization of protein kinase C delta (PKCδ)-Smac interactions.IAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosis.A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment.SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells.The RING domain of cIAP1 mediates the degradation of RING-bearing inhibitor of apoptosis proteins by distinct pathways.Multifaceted targeting in cancer: the recent cell death players meet the usual oncogene suspects.Killing of macrophages by anthrax lethal toxin: involvement of the N-end rule pathway.Role of Smac/DIABLO in cancer progression.Ubiquitin ligases in cancer: ushers for degradation.
P2860
Q24304472-E6E3C5EA-7970-486C-9B2E-9F3088BDE9EAQ24323126-6405CA76-EC5F-48B9-95D6-1EAEBE25EA5CQ24338158-F49159C6-E55A-497B-AECA-E509DA27D7C4Q26864204-186988EB-69A1-47F4-8257-926C693F7817Q28114973-7E3BB6EA-4808-4B81-B74B-5DA500C700ECQ28250105-BBE23D0A-0B24-4D53-98F9-0F4B506BFAA9Q28262381-74836FD0-C43E-436A-B455-03FD7B01E0D1Q28266432-5A2A5D4C-3EE5-446E-B173-93A75C5355A6Q28303498-6E0064D2-1DF9-4F33-B04F-C31DE6585AFCQ33261665-CF3A1875-28A5-4A35-AE5A-BC03B3B7D149Q33263114-EB035849-F00D-4746-AFDC-7C955AEB59DEQ33417259-1220239A-BE99-4164-9A1D-1B4EB338A9FDQ33589984-B27582BF-AC30-45BD-8875-D924113F7C2EQ33615280-6D53D8BD-565C-4CE6-8282-9D27AC5E59B0Q33721855-9AD1E152-9878-45E7-9FFC-CC71F78D58F0Q33885155-F9AEAF21-AD68-4C66-BE52-870564EC93CDQ33896931-32757737-146A-466D-AFC2-8ACCCF112884Q34132152-E7BE289A-97E5-4FB4-9D70-C46868E1205BQ34144567-13891DB7-3C8D-45EA-82CB-5D39FE5781C4Q34222388-B7826038-5566-455B-9988-B457A9F3147AQ34289261-95BC7FC3-3B1C-4588-A92F-6E6F31398079Q34382271-45F60812-B3DD-4878-BC2A-D136F55EC59BQ34547602-A51F6711-84C6-449E-9247-EC1F8455E397Q34602140-FADB670F-723D-4857-8C4A-69C920EB7971Q34654418-1356CB1D-8716-411B-B0B2-144798868829Q35016039-F9DEBF53-53E2-427E-8EAD-6462B10B4494Q35069365-1361691B-BB57-4AA7-A765-61E3C03F42CAQ35111028-B59408D2-5ACA-486C-9F8D-E2DB46A94447Q35175936-BA87E5C8-6BCD-4FF2-A02F-0F6D2B0B63C0Q35687102-89C72D83-4547-4CD6-8801-5185148941A1Q35804937-2F57642E-7B63-4252-A0D5-A4ECF8B90AE4Q36027232-C303D47C-840E-4CCD-8D81-1069774B378CQ36103378-99348171-D0AC-4661-95A2-C9AFA9AF8758Q36460712-B0B03808-BC9E-4C72-BFB8-3F4C3E773FA7Q36545758-E1D4DA10-FE0F-46B2-85C7-1D8C0B60CDBFQ36739928-B99A1434-2E12-49D3-91F6-6D44E7F00400Q36804432-45B90163-AFDF-46E2-A82A-124E25E54328Q36817991-938DA09E-B199-4CE7-912B-514B7743BBAEQ36934716-D7D01612-B354-4C3B-8315-3E94130F7408Q36946774-72AC8A76-F12B-4DB6-8DC0-E2C922B0C923
P2860
Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Smac/DIABLO selectively reduce ...... XIAP and livin in HeLa cells.
@en
Smac/DIABLO selectively reduce ...... XIAP and livin in HeLa cells.
@nl
type
label
Smac/DIABLO selectively reduce ...... XIAP and livin in HeLa cells.
@en
Smac/DIABLO selectively reduce ...... XIAP and livin in HeLa cells.
@nl
prefLabel
Smac/DIABLO selectively reduce ...... XIAP and livin in HeLa cells.
@en
Smac/DIABLO selectively reduce ...... XIAP and livin in HeLa cells.
@nl
P2860
P356
P1476
Smac/DIABLO selectively reduce ...... XIAP and livin in HeLa cells.
@en
P2093
Chunying Du
Qi-Heng Yang
P2860
P304
16963-16970
P356
10.1074/JBC.M401253200
P407
P577
2004-02-11T00:00:00Z